Home › Hartziekten

Hartziekten klinische studies rekruteren in de VS

71 studies voor Hartziekten rekruteren deelnemers op locaties doorheen de Verenigde Staten.

Steden met de meeste studies

• New York City, NY18 studies
• Boston, MA14 studies
• Cleveland, OH13 studies
• Los Angeles, CA12 studies
• Portland, OR11 studies
• Philadelphia, PA11 studies
• Atlanta, GA10 studies
• Rochester, MN10 studies
• Durham, NC10 studies
• Dallas, TX10 studies
• Washington, DC9 studies
• Baltimore, MD9 studies
• Phoenix, AZ9 studies
• St. Louis, MO9 studies
• Chicago, IL9 studies
• Houston, TX9 studies
• Indianapolis, IN9 studies
• Pittsburgh, PA9 studies
• Columbus, OH8 studies
• Cincinnati, OH8 studies
• San Francisco, CA8 studies
• Nashville, TN7 studies
• San Diego, CA7 studies
• Austin, TX7 studies
• Minneapolis, MN6 studies
• Charleston, SC6 studies
• Newark, NJ6 studies
• Milwaukee, WI6 studies
• Kansas City, KS5 studies
• Norfolk, VA4 studies
• Tampa, FL4 studies
• Miami, FL4 studies
• Salt Lake City, UT4 studies
• Hartford, CT4 studies
• Ann Arbor, MI4 studies
• Omaha, NE4 studies
• Arlington, VA4 studies
• Louisville, KY4 studies
• Kansas City, MO4 studies
• Mountain View, CA4 studies

Per staat

• Arizona9 studies
• Californië21 studies
• Colorado7 studies
• Connecticut5 studies
• District of Columbia8 studies
• Florida13 studies
• Georgia11 studies
• Illinois12 studies
• Indiana10 studies
• Iowa3 studies
• Kansas5 studies
• Kentucky4 studies
• Louisiana3 studies
• Maryland12 studies
• Massachusetts17 studies
• Michigan9 studies
• Minnesota16 studies
• Missouri12 studies
• Nebraska4 studies
• New Jersey9 studies
• New York20 studies
• North Carolina12 studies
• Ohio19 studies
• Oklahoma4 studies
• Oregon11 studies
• Pennsylvania15 studies
• South Carolina6 studies
• Tennessee9 studies
• Texas16 studies
• Utah6 studies
• Vermont3 studies
• Virginia9 studies
• Washington5 studies
• West Virginia3 studies
• Wisconsin7 studies

Recent bijgewerkte studies

Officiële studietekst (Engels)

Van ClinicalTrials.gov, gegevens opgehaald op 3 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.